Design and optimization of lentiviral vectors for transfer of GALC expression in Twitcher brain

Diego Dolcetta, L. Perani, M. I. Givogri, F. Galbiati, S. Amadio, U. Del Carro, G. Finocchiaro, A. Fanzani, S. Marchesini, L. Naldini, M. G. Roncarolo, Ernesto Bongarzone

Research output: Contribution to journalArticle

Abstract

Background: Demyelination in globoid cell leukodystrophy (GLD) is due to a deficiency of galactocerebrosidase (GALC) activity. Up to now, in vivo brain viral gene transfer of GALC showed modest impact on disease development in Twitcher mice, an animal model for GLD. Lentiviral vectors, which are highly efficient to transfer the expression of therapeutic genes in neurons and glial cells, have not been evaluated for direct cerebral therapy in GLD mice. Methods: Lentiviral vectors containing the untagged cDNA or the hemagglutinin (HA)-tagged cDNA for the full-length mouse GALC sequence were generated and validated in vitro. In vivo therapeutic efficacy of these vectors was evaluated by histology, biochemistry and electrophysiology after transduction of ependymal or subependymal layers in young Twitcher pups. Results: Both GALC lentiviral vectors transduced neurons, oligodendrocytes and astrocytes with efficiencies above 75% and conferred high levels of enzyme activity. GALC accumulated in lysosomes of transduced cells and was also secreted to the extracellular medium. Conditioned GALC medium was able to correct the enzyme deficiency when added to non-transduced Twitcher glial cultures. Mice that received intraventricular injections of GALC vector showed accumulation of GALC in ependymal cells but no diffusion of the enzyme from the ependymal ventricular tree into the cerebral parenchyma. Significant expression of GALC-HA was detected in neuroglioblasts when GALC-HA lentiviral vectors were injected in the subventricular zone of Twitcher mice. Life span and motor conduction in both groups of treated Twitcher mice were not significantly ameliorated. Conclusions: Lentiviral vectors showed to be efficient for reconstitution of the GALC expression in Twitcher neural cells. GALC was able to accumulate in lysosomes as well as to enter the secretory pathway of lysosomal enzymes, two fundamental aspects for gene therapy of lysosomal storage diseases. Our in vivo results, while showing the capacity of lentiviral vectors to transfer expression of therapeutic GALC in the Twitcher brain, did not limit progression of disease in Twitchers and highlight the need to evaluate other routes of administration.

Original languageEnglish
Pages (from-to)962-971
Number of pages10
JournalJournal of Gene Medicine
Volume8
Issue number8
DOIs
Publication statusPublished - Aug 2006

Fingerprint

Galactosylceramidase
Brain
Globoid Cell Leukodystrophy
Hemagglutinins
Enzymes
Lysosomes
Neuroglia
Complementary DNA
Intraventricular Injections
Lysosomal Storage Diseases
Neurons
Viral Genes
Lateral Ventricles
Electrophysiology
Secretory Pathway
Oligodendroglia
Demyelinating Diseases
Therapeutics
Conditioned Culture Medium

Keywords

  • Galactocerebrosidase
  • Krabbe
  • Lentiviral
  • Lysosomes
  • Myelin
  • Twitcher

ASJC Scopus subject areas

  • Genetics

Cite this

Dolcetta, D., Perani, L., Givogri, M. I., Galbiati, F., Amadio, S., Del Carro, U., ... Bongarzone, E. (2006). Design and optimization of lentiviral vectors for transfer of GALC expression in Twitcher brain. Journal of Gene Medicine, 8(8), 962-971. https://doi.org/10.1002/jgm.924

Design and optimization of lentiviral vectors for transfer of GALC expression in Twitcher brain. / Dolcetta, Diego; Perani, L.; Givogri, M. I.; Galbiati, F.; Amadio, S.; Del Carro, U.; Finocchiaro, G.; Fanzani, A.; Marchesini, S.; Naldini, L.; Roncarolo, M. G.; Bongarzone, Ernesto.

In: Journal of Gene Medicine, Vol. 8, No. 8, 08.2006, p. 962-971.

Research output: Contribution to journalArticle

Dolcetta, D, Perani, L, Givogri, MI, Galbiati, F, Amadio, S, Del Carro, U, Finocchiaro, G, Fanzani, A, Marchesini, S, Naldini, L, Roncarolo, MG & Bongarzone, E 2006, 'Design and optimization of lentiviral vectors for transfer of GALC expression in Twitcher brain', Journal of Gene Medicine, vol. 8, no. 8, pp. 962-971. https://doi.org/10.1002/jgm.924
Dolcetta, Diego ; Perani, L. ; Givogri, M. I. ; Galbiati, F. ; Amadio, S. ; Del Carro, U. ; Finocchiaro, G. ; Fanzani, A. ; Marchesini, S. ; Naldini, L. ; Roncarolo, M. G. ; Bongarzone, Ernesto. / Design and optimization of lentiviral vectors for transfer of GALC expression in Twitcher brain. In: Journal of Gene Medicine. 2006 ; Vol. 8, No. 8. pp. 962-971.
@article{c6fa6ad5014b4c729400ca3105da511c,
title = "Design and optimization of lentiviral vectors for transfer of GALC expression in Twitcher brain",
abstract = "Background: Demyelination in globoid cell leukodystrophy (GLD) is due to a deficiency of galactocerebrosidase (GALC) activity. Up to now, in vivo brain viral gene transfer of GALC showed modest impact on disease development in Twitcher mice, an animal model for GLD. Lentiviral vectors, which are highly efficient to transfer the expression of therapeutic genes in neurons and glial cells, have not been evaluated for direct cerebral therapy in GLD mice. Methods: Lentiviral vectors containing the untagged cDNA or the hemagglutinin (HA)-tagged cDNA for the full-length mouse GALC sequence were generated and validated in vitro. In vivo therapeutic efficacy of these vectors was evaluated by histology, biochemistry and electrophysiology after transduction of ependymal or subependymal layers in young Twitcher pups. Results: Both GALC lentiviral vectors transduced neurons, oligodendrocytes and astrocytes with efficiencies above 75{\%} and conferred high levels of enzyme activity. GALC accumulated in lysosomes of transduced cells and was also secreted to the extracellular medium. Conditioned GALC medium was able to correct the enzyme deficiency when added to non-transduced Twitcher glial cultures. Mice that received intraventricular injections of GALC vector showed accumulation of GALC in ependymal cells but no diffusion of the enzyme from the ependymal ventricular tree into the cerebral parenchyma. Significant expression of GALC-HA was detected in neuroglioblasts when GALC-HA lentiviral vectors were injected in the subventricular zone of Twitcher mice. Life span and motor conduction in both groups of treated Twitcher mice were not significantly ameliorated. Conclusions: Lentiviral vectors showed to be efficient for reconstitution of the GALC expression in Twitcher neural cells. GALC was able to accumulate in lysosomes as well as to enter the secretory pathway of lysosomal enzymes, two fundamental aspects for gene therapy of lysosomal storage diseases. Our in vivo results, while showing the capacity of lentiviral vectors to transfer expression of therapeutic GALC in the Twitcher brain, did not limit progression of disease in Twitchers and highlight the need to evaluate other routes of administration.",
keywords = "Galactocerebrosidase, Krabbe, Lentiviral, Lysosomes, Myelin, Twitcher",
author = "Diego Dolcetta and L. Perani and Givogri, {M. I.} and F. Galbiati and S. Amadio and {Del Carro}, U. and G. Finocchiaro and A. Fanzani and S. Marchesini and L. Naldini and Roncarolo, {M. G.} and Ernesto Bongarzone",
year = "2006",
month = "8",
doi = "10.1002/jgm.924",
language = "English",
volume = "8",
pages = "962--971",
journal = "Journal of Gene Medicine",
issn = "1099-498X",
publisher = "John Wiley and Sons Ltd",
number = "8",

}

TY - JOUR

T1 - Design and optimization of lentiviral vectors for transfer of GALC expression in Twitcher brain

AU - Dolcetta, Diego

AU - Perani, L.

AU - Givogri, M. I.

AU - Galbiati, F.

AU - Amadio, S.

AU - Del Carro, U.

AU - Finocchiaro, G.

AU - Fanzani, A.

AU - Marchesini, S.

AU - Naldini, L.

AU - Roncarolo, M. G.

AU - Bongarzone, Ernesto

PY - 2006/8

Y1 - 2006/8

N2 - Background: Demyelination in globoid cell leukodystrophy (GLD) is due to a deficiency of galactocerebrosidase (GALC) activity. Up to now, in vivo brain viral gene transfer of GALC showed modest impact on disease development in Twitcher mice, an animal model for GLD. Lentiviral vectors, which are highly efficient to transfer the expression of therapeutic genes in neurons and glial cells, have not been evaluated for direct cerebral therapy in GLD mice. Methods: Lentiviral vectors containing the untagged cDNA or the hemagglutinin (HA)-tagged cDNA for the full-length mouse GALC sequence were generated and validated in vitro. In vivo therapeutic efficacy of these vectors was evaluated by histology, biochemistry and electrophysiology after transduction of ependymal or subependymal layers in young Twitcher pups. Results: Both GALC lentiviral vectors transduced neurons, oligodendrocytes and astrocytes with efficiencies above 75% and conferred high levels of enzyme activity. GALC accumulated in lysosomes of transduced cells and was also secreted to the extracellular medium. Conditioned GALC medium was able to correct the enzyme deficiency when added to non-transduced Twitcher glial cultures. Mice that received intraventricular injections of GALC vector showed accumulation of GALC in ependymal cells but no diffusion of the enzyme from the ependymal ventricular tree into the cerebral parenchyma. Significant expression of GALC-HA was detected in neuroglioblasts when GALC-HA lentiviral vectors were injected in the subventricular zone of Twitcher mice. Life span and motor conduction in both groups of treated Twitcher mice were not significantly ameliorated. Conclusions: Lentiviral vectors showed to be efficient for reconstitution of the GALC expression in Twitcher neural cells. GALC was able to accumulate in lysosomes as well as to enter the secretory pathway of lysosomal enzymes, two fundamental aspects for gene therapy of lysosomal storage diseases. Our in vivo results, while showing the capacity of lentiviral vectors to transfer expression of therapeutic GALC in the Twitcher brain, did not limit progression of disease in Twitchers and highlight the need to evaluate other routes of administration.

AB - Background: Demyelination in globoid cell leukodystrophy (GLD) is due to a deficiency of galactocerebrosidase (GALC) activity. Up to now, in vivo brain viral gene transfer of GALC showed modest impact on disease development in Twitcher mice, an animal model for GLD. Lentiviral vectors, which are highly efficient to transfer the expression of therapeutic genes in neurons and glial cells, have not been evaluated for direct cerebral therapy in GLD mice. Methods: Lentiviral vectors containing the untagged cDNA or the hemagglutinin (HA)-tagged cDNA for the full-length mouse GALC sequence were generated and validated in vitro. In vivo therapeutic efficacy of these vectors was evaluated by histology, biochemistry and electrophysiology after transduction of ependymal or subependymal layers in young Twitcher pups. Results: Both GALC lentiviral vectors transduced neurons, oligodendrocytes and astrocytes with efficiencies above 75% and conferred high levels of enzyme activity. GALC accumulated in lysosomes of transduced cells and was also secreted to the extracellular medium. Conditioned GALC medium was able to correct the enzyme deficiency when added to non-transduced Twitcher glial cultures. Mice that received intraventricular injections of GALC vector showed accumulation of GALC in ependymal cells but no diffusion of the enzyme from the ependymal ventricular tree into the cerebral parenchyma. Significant expression of GALC-HA was detected in neuroglioblasts when GALC-HA lentiviral vectors were injected in the subventricular zone of Twitcher mice. Life span and motor conduction in both groups of treated Twitcher mice were not significantly ameliorated. Conclusions: Lentiviral vectors showed to be efficient for reconstitution of the GALC expression in Twitcher neural cells. GALC was able to accumulate in lysosomes as well as to enter the secretory pathway of lysosomal enzymes, two fundamental aspects for gene therapy of lysosomal storage diseases. Our in vivo results, while showing the capacity of lentiviral vectors to transfer expression of therapeutic GALC in the Twitcher brain, did not limit progression of disease in Twitchers and highlight the need to evaluate other routes of administration.

KW - Galactocerebrosidase

KW - Krabbe

KW - Lentiviral

KW - Lysosomes

KW - Myelin

KW - Twitcher

UR - http://www.scopus.com/inward/record.url?scp=33747842839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747842839&partnerID=8YFLogxK

U2 - 10.1002/jgm.924

DO - 10.1002/jgm.924

M3 - Article

C2 - 16732552

AN - SCOPUS:33747842839

VL - 8

SP - 962

EP - 971

JO - Journal of Gene Medicine

JF - Journal of Gene Medicine

SN - 1099-498X

IS - 8

ER -